Author:
Geertsema L,Van Marle A-C,Janse van Rensburg Walter J
Publisher
South African Medical Association NPC
Reference10 articles.
1. Vaughan JL, Wiggil TM, Alli N, Hodkinson K. The prevalence of HIV seropositivity and associated cytopenias in full blood counts processed at an academic laboratory in Soweto, South Africa. S Afr Med J 2017;107(3):264-269. https://doi.org/10.7196/samj.2017.v107i3.11206
2. Scaradavou A. HIV-related thrombocytopenia. Blood Rev 2002;16(1):73-76. https://doi. org/10.1054/blre.2001.0188
3. Vannappagari V, Nkhoma ET, Atashili J, Laurent SS, Zhao H. Prevalence, severity, and duration of thrombocytopenia among HIV patients in the era of highly active antiretroviral therapy. Platelets 2011;22(8):611-618. https://doi.org/10.3109/09537104.2011.582526
4. Ambler KL, Vickars LM, Leger CS, et al. Clinical features, treatment, and outcome of HIV- associated immune thrombocytopenia in the HAART era. Adv Haem 2012;2012:910954. https:// doi.org/10.1155%2F2012%2F910954
5. O’Bryan TA, Okulicz JF, Bradley WP, Ganesan A, Wang X, Agan BK. Impact of the highly active antiretroviral therapy era on the epidemiology of primary HIV-associated thrombocytopenia. BMC Rs Notes 2015;8(1):1-5.